Pierre-Yves Dumas

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Natural Killer Cells

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Harmony Leroy, Noémie Gadaud, Emilie Bérard, Emilie Klein, Isabelle Luquet, Jean-Philippe Vial, Jean-Baptiste Rieu, Nicolas Lechevalier, Suzanne Tavitian, Thibaut Leguay, Laetitia Largeaud, Audrey Bidet, Eric Delabesse, Audrey Sarry, Anne-Charlotte de Grande, Christian Recher, Arnaud Pigneux, Sarah Bertoli, Pierre-Yves Dumas
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy. Cancer medicine 13 (3) (2024)
Harmony Leroy, Noémie Gadaud, Emilie Bérard, Emilie Klein, Isabelle Luquet, Jean-Philippe Vial, Jean-Baptiste Rieu, Nicolas Lechevalier, Suzanne Tavitian, Thibaut Leguay, Laetitia Largeaud, Audrey Bidet, Eric Delabesse, Audrey Sarry, Anne-Charlotte de Grande, Christian Recher, Arnaud Pigneux, Sarah Bertoli, Pierre-Yves Dumas
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy. Cancer medicine 13 (3) (2024)
Loic Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Mael Heiblig, Pierre-Yves Dumas, Christian Récher, Celine Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling H Cheok, Raphaël A Itzykson, Nicolas Duployez
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. Blood advances (2023)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Christoph Röllig, Martin Bornhäuser, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Christoph Röllig, Martin Bornhäuser, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Marine Dupont, Mathilde Huart, Claire Lauvinerie, Audrey Bidet, Amélie Valérie Guitart, Arnaud Villacreces, Isabelle Vigon, Vanessa Desplat, Ali El-Habhab, Arnaud Pigneux, Zoran Ivanovic, Philippe Brunet de la Grange, Pierre-Yves Dumas, Jean Max Pasquet
Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells. Cancers 14 (2) (2022)
Louise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Recher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne-Sophie Michallet
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy. Cancer medicine (2022)
Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, Sarah Bertoli, Lauris Gastaud, Célestine Simand, Sylvain P Chantepie, Madalina Uzunov, Alexis Genthon, Celine Berthon, Edmond Chiche, Pierre-Yves Dumas, Jacques Vargaftig, Géraldine Salmeron, Emilie Lemasle, Emmanuelle Tavernier, Jérémy Delage, Marion Loirat, Nadine Morineau, Félix Blanc-Durand, Patricia Pautier, Véronique Vergé, Nathalie Auger, Myrtille Thomas, Laetitia Stefani, Marion Lepelley, Thomas Boyer, Sylvain Thépot, Marie-Pierre Gourin, Pascal Bourquard, Matthieu Duchmann, Pierre-Marie Morice, Mauricette Michallet, Lionel Ades, Pierre Fenaux, Christian Recher, Hervé Dombret, Arnaud Pagès, Christophe Marzac, Alexandra Leary, Jean-Baptiste Micol, null null
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Pierre-Yves Dumas, Emmanuel Raffoux, Emilie Bérard, Sarah Bertoli, Marie-Anne Hospital, Mael Heiblig, Yohann Desbrosses, Caroline Bonmati, Cécile Pautas, Juliette Lambert, Corentin Orvain, Anne Banos, Florence Pasquier, Pierre Peterlin, Tony Marchand, Madalina Uzunov, Jamilé Frayfer, Pascal Turlure, Thomas Cluzeau, Eric Jourdan, Chantal Himberlin, Emmanuelle Tavernier, Alban Villate, Stephanie Haiat, Marie-Lorraine Chretien, Martin Carre, Sylvain Chantepie, Ioana Vaida, Mathieu Wemeau, Safia Chebrek, Gaelle Guillerm, Romain Guièze, Houria Debarri, Eve Gehlkopf, Kamel Laribi, Ambroise Marçais, Alberto Santagostino, Marie Christine Bene, Ariane Mineur, Arnaud Pigneux, Hervé Dombret, Christian Recher
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO. Leukemia (2022)
Jean Galtier, Camille Alric, Emilie Bérard, Thibaut Leguay, Suzanne Tavitian, Audrey Bidet, Eric Delabesse, Jean Baptiste Rieu, Jean-Philippe Vial, François Vergez, Nicolas Lechevalier, Isabelle Luquet, Emilie Klein, Anne-Charlotte de Grande, Audrey Sarry, Arnaud Pigneux, Christian Recher, Sarah Bertoli, Pierre-Yves Dumas
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes. Blood cancer journal 11 (11) (2021)
Pierre-Yves Dumas, Arnaud Villacreces, Amélie Valérie Guitart, Ali El-Habhab, Layal Massara, Olivier Mansier, Audrey Bidet, Delphine Martineau, Solene Fernandez, Thibaut Leguay, Arnaud Pigneux, Isabelle Vigon, Jean-Max Pasquet, Vanessa Desplat
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Alyssa Benarfa, Anne Pham-Ledard, Emilie Gérard, Laure Dequidt, Océane Ducharme, Pierre-Yves Dumas, Marie Beylot-Barry
Vindesine dexamethasone as a therapeutic option in elderly blastic plasmacytoid dendritic cell neoplasms: a monocentric experience. Leukemia & lymphoma 62 (10) (2021)
Christian Recher, Christoph Röllig, Emilie Bérard, Sarah Bertoli, Pierre-Yves Dumas, Suzanne Tavitian, Michael Kramer, Hubert Serve, Martin Bornhäuser, Uwe Platzbecker, Carsten Muller-Tidow, Claudia D Baldus, David Martínez-Cuadrón, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez Arbolí, Cristina Gil, Juan Bergua, Teresa Bernal, Adolfo de la Fuente Burguera, Eric Delabesse, Audrey Bidet, Arnaud Pigneux, Pau Montesinos
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries. Leukemia (2021)
Raynier Devillier, Edouard Forcade, Alice Garnier, Sarah Guenounou, Sylvain Thépot, Gaelle Guillerm, Patrice Ceballos, Yosr Hicheri, Pierre-Yves Dumas, Pierre Peterlin, Mathilde M Hunault-Berger, Marie Christine Bene, Anne Bouvier, Patrice Chevallier, Didier Blaise, Norbert Vey, Arnaud Pigneux, Christian Recher, Anne Huynh
In-depth time-dependent analysis of the benefit of Allo-HSCT for elderly patients with CR1 AML: a FILO study. Blood advances (2021)
Laetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, Pierre-Yves Dumas, Naïs Prade, Stéphanie Dufrechou, Julien Plenecassagnes, Isabelle Luquet, Odile Blanchet, Anne Banos, Marie Christine Bene, Marc Bernard, Sarah Bertoli, Caroline Bonmati, Luc Matthieu Fornecker, Romain Guièze, Lamya Haddaoui, Mathilde Hunault, Jean Christophe Ianotto, Eric Jourdan, Mario Ojeda, Pierre Peterlin, Norbert Vey, Hacene Zerazhi, Hicheri Yosr, Ariane Mineur, Jean-Yves Cahn, Norbert Ifrah, Christian Recher, Arnaud Pigneux, Eric Delabesse, null null
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study. Leukemia 35 (5) (2020)
Pierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, Laetitia Largeaud, Audrey Bidet, Eric Delabesse, Thibaut Leguay, Harmony Leroy, Noémie Gadaud, Jean Baptiste Rieu, Jean-Philippe Vial, François Vergez, Nicolas Lechevalier, Isabelle Luquet, Emilie Klein, Audrey Sarry, Anne-Charlotte de Grande, Arnaud Pigneux, Christian Recher
Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study. Cancers 12 (8) (2020)
Laura Chiossone, Pierre-Yves Dumas, Margaux Vienne, Éric Vivier
Natural killer cells and other innate lymphoid cells in cancer. Nature reviews. Immunology 18 (11) (2019)
Pierre-Yves Dumas, Emilie Bérard, Claire Bréal, Stéphanie Dulucq, Delphine Rea, Franck Nicolini, Edouard Forcade, Melody Dufossée, Jean-Max Pasquet, Béatrice Turcq, Audrey Bidet, Noel Milpied, Julie Déchanet-Merville, Xavier Lafarge, Gabriel Etienne, François-Xavier Mahon, null null
Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remission. Cancer medicine 8 (11) (2019)